Please join upcoming webinar organized by our Hong Kong team in conjunction with the Hong Kong Society of Congenital and Structural Heart Disease, the Hong Kong Society of Transcatheter ENdo-cardiovascular Therapeutics (HKSTENT) and sponsored by OrbusNeich P&F.

The 90 minute session will contain presentations by key physicians from Hong Kong, together with case examples and discussion opportunities about the advancements in managing Tricuspid valve regurgitation.

For quick access to registration:

We look forward to your participation at this collaborate event.